vs
Side-by-side financial comparison of EASTERN CO (EML) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $55.3M, roughly 1.4× EASTERN CO). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -22.4%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $3.1M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -0.6%).
EASTERN COEMLEarnings & Financial Report
China Eastern Airlines is a major airline in China, headquartered in Changning, Shanghai. It is one of the three major airlines in the country, along with Air China and China Southern Airlines.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
EML vs PBYI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.3M | $75.5M |
| Net Profit | $578.9K | — |
| Gross Margin | 22.3% | 69.3% |
| Operating Margin | 3.1% | 22.7% |
| Net Margin | 1.0% | — |
| Revenue YoY | -22.4% | 27.7% |
| Net Profit YoY | 103.8% | — |
| EPS (diluted) | $0.10 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.5M | ||
| Q3 25 | $55.3M | $54.5M | ||
| Q2 25 | $70.2M | $52.4M | ||
| Q1 25 | $63.3M | $46.0M | ||
| Q4 24 | $64.3M | $59.1M | ||
| Q3 24 | $71.3M | $80.5M | ||
| Q2 24 | $72.6M | $47.1M | ||
| Q1 24 | $64.6M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $578.9K | $8.8M | ||
| Q2 25 | $3.4M | $5.9M | ||
| Q1 25 | $1.9M | $3.0M | ||
| Q4 24 | $1.3M | — | ||
| Q3 24 | $-15.3M | $20.3M | ||
| Q2 24 | $3.5M | $-4.5M | ||
| Q1 24 | $1.9M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | 22.3% | 77.7% | ||
| Q2 25 | 23.3% | 76.5% | ||
| Q1 25 | 22.4% | 77.1% | ||
| Q4 24 | 23.6% | 76.4% | ||
| Q3 24 | 25.5% | 63.9% | ||
| Q2 24 | 25.4% | 77.4% | ||
| Q1 24 | 23.9% | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | 3.1% | 17.6% | ||
| Q2 25 | 4.5% | 12.7% | ||
| Q1 25 | 5.1% | 8.7% | ||
| Q4 24 | 6.1% | 22.6% | ||
| Q3 24 | 9.5% | 27.4% | ||
| Q2 24 | 8.3% | -4.6% | ||
| Q1 24 | 5.3% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | 1.0% | 16.2% | ||
| Q2 25 | 4.9% | 11.2% | ||
| Q1 25 | 3.1% | 6.5% | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | -21.5% | 25.2% | ||
| Q2 24 | 4.8% | -9.6% | ||
| Q1 24 | 3.0% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | $0.10 | $0.17 | ||
| Q2 25 | $0.56 | $0.12 | ||
| Q1 25 | $0.32 | $0.06 | ||
| Q4 24 | $0.22 | $0.40 | ||
| Q3 24 | $-2.46 | $0.41 | ||
| Q2 24 | $0.56 | $-0.09 | ||
| Q1 24 | $0.31 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.2M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $124.3M | $130.3M |
| Total Assets | $220.0M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | $9.2M | $94.4M | ||
| Q2 25 | $9.1M | $96.0M | ||
| Q1 25 | $10.2M | $93.2M | ||
| Q4 24 | $16.1M | $101.0M | ||
| Q3 24 | $9.7M | $96.7M | ||
| Q2 24 | $2.0M | $96.8M | ||
| Q1 24 | $2.1M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $42.2M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | $124.3M | $115.3M | ||
| Q2 25 | $124.4M | $104.7M | ||
| Q1 25 | $121.0M | $97.1M | ||
| Q4 24 | $120.7M | $92.1M | ||
| Q3 24 | $119.2M | $71.1M | ||
| Q2 24 | $136.5M | $48.5M | ||
| Q1 24 | $134.5M | $51.0M |
| Q4 25 | — | $216.3M | ||
| Q3 25 | $220.0M | $202.9M | ||
| Q2 25 | $229.4M | $194.9M | ||
| Q1 25 | $232.3M | $196.2M | ||
| Q4 24 | $235.3M | $213.3M | ||
| Q3 24 | $244.2M | $220.7M | ||
| Q2 24 | $255.9M | $205.0M | ||
| Q1 24 | $253.9M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.35× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.1M | $14.4M |
| Free Cash FlowOCF − Capex | $3.1M | $14.4M |
| FCF MarginFCF / Revenue | 5.5% | 19.1% |
| Capex IntensityCapex / Revenue | 0.1% | 0.0% |
| Cash ConversionOCF / Net Profit | 5.38× | — |
| TTM Free Cash FlowTrailing 4 quarters | $12.3M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | $3.1M | $9.7M | ||
| Q2 25 | $3.8M | $14.1M | ||
| Q1 25 | $-1.8M | $3.6M | ||
| Q4 24 | $11.0M | $15.6M | ||
| Q3 24 | $-2.9M | $11.0M | ||
| Q2 24 | $8.4M | $1.0M | ||
| Q1 24 | $2.8M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | $3.1M | $9.7M | ||
| Q2 25 | $3.0M | $14.1M | ||
| Q1 25 | $-2.7M | $3.6M | ||
| Q4 24 | $9.0M | $15.6M | ||
| Q3 24 | $-7.7M | $11.0M | ||
| Q2 24 | $7.3M | $1.0M | ||
| Q1 24 | $1.1M | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | 5.5% | 17.7% | ||
| Q2 25 | 4.3% | 26.8% | ||
| Q1 25 | -4.3% | 7.7% | ||
| Q4 24 | 13.9% | 26.4% | ||
| Q3 24 | -10.8% | 13.7% | ||
| Q2 24 | 10.1% | 2.1% | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 3.2% | 0.0% | ||
| Q3 24 | 6.7% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 2.6% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 5.38× | 1.10× | ||
| Q2 25 | 1.09× | 2.41× | ||
| Q1 25 | -0.95× | 1.21× | ||
| Q4 24 | 8.41× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 2.40× | — | ||
| Q1 24 | 1.43× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
